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Popular Science 
Nanotechnology is a rapidly growing field. It includes fabrication of very small particles 
(nanoparticles). There are different types of nanoparticles depending on the material source.  
Some nanoparticles are used as a vehicle to deliver drugs to cells (e.g. cancer cells). Due to 
their large surface area relative to their volume, they can carry large amount of drugs. 
Nanoparticles can aggregate in salty solutions as in normal human blood. Specific molecules 
can be added to the particles surface to prevent aggregation. One of the widely used 
particles is gold nanoparticles. They can have different shapes like spheres and rods.  One of 
the advantages of using gold nanoparticles is that the behavior of the particles in the solution 
can be detected primarily by the color. A purple colored means that small particles are stable 
in solution. While grey color is an indication of particle aggregation. When a particle enters 
blood the particle surface starts to interact with components in blood. Some components 
interact strongly while other interacts weakly with the particle surface. Proteins is one 
component in blood that often interacts with nanoparticles. Some proteins aggregate the 
particles and others not. Different techniques are used to measure the size of the particles in 
protein rich medium. Comparing the particles size naked particles in protein rich medium 
with protein conjugated particles, gives information about if the protein cause aggregations 
of the particles or not.  Studying the effect of proteins on nanoparticles is important to 
evaluate the particle toxicity, safety, and suitability as drug carrier. 
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Abbreviations 
 
NPs Nanoparticles  
PEG Polyethylene glycol  
GNPs Gold nanoparticles  
HAuCL4 Chloroauric acid  
MPS Mononuclear phagocytic system 
PGB1 B1 immuniglobulin binding domain of streptococcal protein G  
IgG Immunoglobulin G  
DLS Dynamic light scattering 
FCS Fetal calf serum  
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline  
PDB Protein data bank 
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Abstract 
 
Nanoparticles (NPs) are the particles between 1 and 100 nm.  They are widely used in the 
medical field as delivery vehicles, therapeutics and contrast agents in cancer diagnosis and 
treatment. There are different types of NPs divided according to the source of used 
materials. The agglomeration of NPs can be prevented by adding different polymers to their 
surfaces. The optical properties of gold nanoparticles (GNPs) make them a good system for 
following the behaviour of NPs in vivo. The surface properties are determined according to 
the purpose and type of the target. The protein layers covering GNPs is called corona. The 
composition of corona depends on the particle material, size and surface properties. In this 
study, different methods (DLS, disc centrifuge and SDS-PAGE) were used to investigate the 
effect of different proteins, including PGB1, IgG and plasma proteins (cow and calf) on the 
aggregation of GNPs and how these aggregations could be prevented. It was found that 
PGB1 did not aggregate the particles while IgG did and the amount of aggregation depends 
on IgG concentration. In addition, PBS aggregated the particles while the water stabilized 
them.  Finally, some experiments were done on carboxylated and biotinylated GNPs trying to 
conjugate to PGB1 and streptavidin respectively, but the results were unclear and more 
studies are needed.  
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1. Introduction 
1.1 Nanoparticles and drug delivery system  
 
     Nanotechnology is a rapidly growing field. It includes fabrication of materials at the 
nanoscale level with novel physical/chemical-properties and functions [1]. One of the most 
important applications of nanotechnology is nanomedicine, which focus mainly on 
development of nanoparticles (NPs), sub-100 nm structures to be used as contrast agents, 
delivery vehicles or therapeutics in diagnosis and treatment of cancer [2]. The importance of 
NPs in the medical field is due to their relatively large surface area, which enable them to 
bind and carry other compounds like proteins, drugs and probes. Although NPs are defined 
as having dimensions below 100 nm, sometimes, bigger NPs could be needed to carry 
sufficient amount of the drug. Moreover, for drug delivery, the drug itself may be fabricated 
in the nanoscale and acts as drug and carrier at the same time instead of using engineered 
particles. The sources of the materials used to make engineered NPs could be biological like 
phospholipids, lipids, lactic acid and dextran or could have chemical properties like polymers, 
carbon and metals. The interactions between NPs and the cells vary according to the type of 
NPs. 
      The main goals for designing drug delivery system are the specificity of drug targeting and 
delivery, reducing the toxicity but saving therapeutic effects at the same time leading to fast 
development of new safe drugs. To design a drug delivery system, the following information 
about the drug should be known and studied, (1) drug integration and release, (2) drug 
stability, (3) biocompatibility, (4) biodistribution and targeting and (5) efficiency. The aims of 
using NPs as drug vehicle are to improve delivery to the target cells and reduce the toxicity 
of the free drug to non-target cells. Coating of NPs using different polymers like polyethylene 
glycol (PEG) can be used to prevent agglomeration of NPs and keep particles in colloidal 
suspension [3]. Pegylated gold nanoparticles (GNPs) is a perfect system to follow in vivo the 
behavior of NPs. This is due to the particles low toxicity, production in monodisperse 
batches, that can be modified chemically and to their optical properties [4]. Many functional 
groups can be attached to GNPs  such as amino group, carboxyl group and biotin. The Choice 
of functional groups, depends on the type of the target and the purpose [5]. 
1.2 Historical background of GNPs 
 
     The GNPs story started when Lycurgus Cup (4th century Roman glass cage cup) was made 
from colloidal gold, which changed its color depending on the direction of light. Later, this is 
become the common staining glass method. In the 17th century, Cassius made a purple 
colored glass by adding tin to gold solution. 
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     Scientific development of nanotechnology actually started when Michael Faraday 
prepared the first pure sample of GNPs. In 1857, he reduced gold chloride by phosphorous 
giving a purple color.  Faraday was the first who explained what happened when the light 
incidents on the glass and changed the color. Gold was dispersed in ruby glass uniformly. 
When the wavelength of the incident light was smaller than the particles, they appeared in 
different colors compared to their original colors. 
     In 1902, Zsigmondy invented ultramicroscope to visualize individual particles. He 
determined the accurate size of the particles and detected interesting properties depending 
on the size and motion of NPs. He studied the changes in gold colors caused by adding salts 
and explained that it might be due to aggregation of particles in different sizes and using 
protective agents like gelatin could prevent aggregation.  
      GNPs are classified according to shape, size and physical properties. The first type of 
produced GNPs was nanospheres. After that, other types like nanorods, nanoshells and 
nanocages were produced. The diameter of gold nanospheres varied from 2 nm to 100 nm 
which synthesized by reducing HAuCl4 (Chloroauric acid) solution by different reducing 
agents. Citrate is a common used reducing agent. The ratio of citrate and gold controls the 
size of nanospheres [6]. 
1.3 The effect of NPs shape, size and surface chemistry 
 
     Once NPs enter a biological fluid, proteins start to compete for binding to NPs forming a 
layer around the particles called corona which can be hard or soft. The strongly adsorbed 
NPs proteins represent the hard layer while weakly interacting serum proteins represent soft 
corona layer.  The soft layer is dynamic and can be changed during the NPs life cycle in vivo.  
The corona composition depends on particle material, size and surface properties [7] . It is 
suggested that the hard corona proteins cover the NPs surface while soft corona proteins 
bind to the hard corona by weak protein-protein interactions [8]. 
  In vitro 
     NPs can interact with different structures on the cell surface membrane. NPs can bind to 
receptors on the membrane without entering the cell and induce a signal cascade. NPs can 
enter through receptor-mediated endocytosis and interact with specific organelles. Another 
way is that NPs interact with different organelles (nucleus, mitochondria, etc.). They can also 
bind at unspecific sites on the cell membrane [9]. 
     There are many factors affecting the behavior of NPs at the nano-bio interface. The nano-
bio interface is defined as the dynamic physicochemical interactions, kinetics and 
thermodynamic exchanges between the biological component surfaces and the 
nanomaterial surface [10]. The size and shape of NPs have a direct effect on the cellular 
uptake. The highest uptake for NPs larger than 100 nm is rods, followed by spheres, cylinders 
and cubes. In contrast, sub-100 nm NPs spheres have higher uptake than rods. The 
interactions of non-spherical NPs with the cell are more complicated than spherical particles. 
6
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For example, ligand coated rod shaped NPs can interact with the cell by two different 
orientations, the long axis will interact with more surface receptors than the short axis. 
      Beside the shape and size of NPs the composition plays an important role in the total cell 
uptake. For example, the endocytosis rate of single walled carbon nanotubes and GNPs, each 
50 nm in diameter, are 10-3 and 10-6 min-1 respectively. This difference can be due to the 
different properties of carbon compared to gold.  In addition, the type of ligand used to coat 
NPs affect the biological response (i.e. the uptake and cytotoxicity when two different 
proteins coated NPs targeting the same receptor are different).  
In vivo 
   Over the past 20 years, animal studies on NPs behavior and distribution in the tissue 
showed that there are some parameters controlling the behavior of NPs.  The surface 
chemistry of NPs determines the type of the protein bound to the surface of NPs and the 
strength of interactions. It is found that the blood half-life for neutral NPs is higher than 
positive charged NPs, which cause some problems like platelet aggregation and hemolysis.  
When NPs administrated into the blood, they are removed by phagocytic cells of the 
mononuclear phagocytic system (MPS) within minutes or hours. By adding PEG to the NPs, 
the blood half-life increases. For GNPs, the blood half-life increases by increasing the length 
of PEG as the protective layer becomes thicker.  
     Besides PEGylation of NPs, the shape, size and surface chemistry also control the blood 
half-life. Rod shaped micelles have ten times longer circulation lifetime than spherical 
micelles. The diameter of intravenously administrated NPs determines their biodistribution 
and pharmacokinetics according to different sizes of interendothelial pores coating the blood 
vessels. NPs diameter 6 nm or smaller, are quickly removed from the body due to excretion 
by kidneys. NPs with 200 nm diameter accumulate in the liver and spleen where they are 
removed by the MPS cells. NPs can also accumulate in the tumor tissues. NPs diameter 
controls their overall accumulation and the tumor penetration depth. NPs diameter between 
30 and 200 nm is favorable to produce long circulating NPs, accumulating inside tumor 
tissues [9]. 
     Sonavane et al. studied the distribution of different sizes of GNPs (15, 50, 100 and 200nm) 
in the mice tissues. They found that 15 nm GNPs had higher distribution in the tissues than 
larger GNPs. They were accumulated in liver, lung, spleen and kidney respectively. 15 and 50 
nm GNPs passed the blood brain barrier and accumulated in the brain [11]. 
1.4 The effect of GNPs conjugation on the attached proteins 
 
     When the protein binds to NPs, it undergoes a conformational change, which effects on 
its function by improving or losing it. For example, when trypsin adsorb to silica surface, the 
enzymatic activity of trypsin decreased 10 times and when it  adsorb to polystyrene surface, 
it lost its proteolytic function completely, which could be due to extensive conformational 
changes. The trypsin function was  regained when the trypsin molecules were removed from 
8 
 
polystyrene and silica surfaces [12]. Sometimes functionalized nanoparticles lose its targeting 
ability when placed in biological environment. For example, transferrin conjugated particles 
could not bind to the target receptors on the cells as the proteins in the media shielded 
them completely [13]. 
1.5 B1 Immunoglobulin-Binding Domain of Streptococcal protein G (PGB1) 
 
     Many infective bacteria have proteins on their surface that allow them to bind strongly to 
immunoglobulins and other host proteins. Protein G, a streptococcal protein, binds to the Fc 
region of human immunoglobulin G (IgG) (appendix II, fig.16). It consists of small binding 
domains separated by linkers. Near the C terminus there is a cell wall anchor. Two (three in 
some strains) of the domains bind to IgG while the other two or three domains bind to 
serum albumin. These binding interactions help the pathogen to escape from the immune 
response of the host. The advantage of IgG binding of protein G domains is used to purify 
antibodies.  The domains are called as B1, B2, etc. (numbering from N terminus). PGB1 is a 
small protein 6 kDa with 56 residues, consists of four stranded β sheets and single α helix 
(appendix II. fig.17) [14]. In this project, PGB1 is used to conjugate with GNPs 
1.6 The interactions between colloidal GNPs and human plasma proteins 
 
     Dobrovolskaia et al. examined the size and charge of 30 and 50 nm colloidal GNPs after 30 
minutes incubation with human blood plasma by Dynamic Light Scattering (DLS) [15]. They 
found that the hydrodynamic diameter for 30 and 50 nm GNPs increased by approximately 
50 nm after the incubation. When the particles bound plasma proteins were digested by 
trypsin, the particles size returned to approximately their pre-incubation diameter. GNPs 
surface charge was measured also before and after plasma incubation. The mean particle 
surface charge increased after incubation (becomes less negative) for both particles sizes. 
1.7 What is driving the aggregation of NPs in the blood? 
 
     Cukalevski et al. studied the effect of IgG and fibrinogen on the aggregation of NPs [16]. 
Sulfonated polystyrene NPs were incubated with cow serum, depleted IgG cow serum and 
fetal calf serum (FCS). The absorbance was measured at 400 nm. Most NPs aggregation 
occurred in the cow serum followed by depleted IgG cow serum and FCS. When isolated 
bovine IgG was added to the depleted IgG cow serum and FCS the aggregation increased 
which means that IgG is playing an important role in NPs aggregations. The particles also 
incubated with fibrinogen. It was found that fibrinogen also caused an aggregation of NPs 
and by adding fibrinogen to FCS, the aggregation increased. The difference between IgG and 
fibrinogen is that fibrinogen undergoes structural changes when it binds to the NPs unlike 
IgG that does not have large structural changes after binding to NPs 
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1.8 Theory behind used methods 
1.8.1 Dynamic Light Scattering (DLS) 
     DLS is a physical technique used to measure the hydrodynamic size (radius or diameter), 
including any hydration of solvent layer surrounding the particles, by illuminating the 
particles with laser light. The particles are moving randomly in the solution all the time 
(Brownian motion) depending on the particle size (the bigger size, the slower movement), 
solvent viscosity (the more viscosity, the slower particles movements) and measuring 
temperature (the higher temperature, the faster particles movements). By fixing 
temperature and viscosity, the size of the particles can be measured according to the 
variations of the scattered light [17]. 
1.8.2 Disc centrifuge 
     The sedimentation of the particles is used to characterize the distribution of the particle 
size. Stoke’s law is used to detect the size distribution of spherical particles by measuring the 
required time for the particles to set at a known distance in a known viscosity and density 
fluid.  The centrifugal sedimentation increases the range of sedimentation studies including 
very small particles.  
The following equation is the Stoke’s law for sedimentation, 
D= {(18η ln (Rf/Ro))/ ((ρp-ρf) ω
2t)} 0.5 
where, D is the particle diameter(cm) ,η is the fluid viscosity (poise), Rf and Ro are final and 
initial radius of rotation respectively (cm), ρp and ρf are the density of the particle and fluid 
respectively (g/ml), ω is the rotational velocity (radians/sec) and t is the required time for 
sedimentation from Ro to Rf (sec).  
  When the centrifuge run at constant speed and temperature, all parameters in the 
equation are constant except the time. The arrival time to the detector depends on the  size 
and density of spherical particles such as gold surrounded by protein shells. The coated 
protein particles sediment slower than uncoated protein particles while the aggregated 
particles will sediment more rapidly [18]. Disc centrifuge can separate particles with less than 
5% size difference. The sedimentation is stabilized by a slight water density gradient which 
are often two different sucrose concentrations determined according to the particles density 
[19]. 
1.8.3 One dimensional sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
     SDS-PAGE is a common technique used to separate biological macromolecules (proteins 
and nucleic acids) in a polyacrylamide gel according to the size. An electric field is applied an 
on the polyacrylamide gel, which causes migration of SDS-treated proteins towards the 
anode. The proteins are treated with SDS in order to have a uniform rod shape and to have a 
constant negative charge to size ratio, so the proteins move through the gel according to 
their size only (i.e. larger proteins move slower than small proteins). The size of the protein 
could be detected by using SDS-treated calibration proteins. After the electrophoresis 
process, the proteins can be detected by staining with Coomassie Brilliant Blue [20]. 
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1.9 Aim of the work 
 
 Study the different effects of water and phosphate buffered saline (PBS) on GNPs 
aggregations and how these aggregations can be prevented. 
 Conjugation of GNPs with PGB1. 
 Study plasma proteins (cow and calf) influence on PGB1 conjugated GNPs. 
 Investigate the effect of IgG on the aggregation of GNPs. 
 
 
   Study the effect of surface GNPs on conjugation process (citrate stabilized, 
carboxylated and biotinylated GNPs).   
 Compare two different methods used to measure the particles size (DLS and disc 
centrifuge). 
2. Materials and Methods  
 
2.1 Used materials 
    Citrate stabilized GNPs with 24 and 26 nm were synthesized with concentrations 1.13 and 
25 mM respectively [21]. In all the experiments, they were diluted 10 times. Cow and FCS 
were purchased from Innovative Research. PGB1 was prepared as described in  [22]. Human 
IgG was purchased from Lee Biosolutions with >98 % purity. Carboxylated and biotinylated, 
20 nm GNPs supplied in USP grade purified water were purchased from Cytodiagnostics. 
Streptavidin with 0.5mg/ml stock concentration was used. Alexa flour 488 was purchased 
from life Technologies. All the dilutions were done using 1xPBS and in some experiments, 
water was used.  
2.2 Used Methods 
DLS 
     Used DLS instrument was Wyatt Dyna pro plate reader II connected to Dynamics software 
for analyzing DLS measurements. Corning® 96 Well Polystyrene plate was used. The 
measuring temperature was 25oC.  The volume of the measured samples was 100 µl. 
Disc centrifuge 
 CPS disc centrifuge model DC24000 was used to measure the particles in range 0.01μm to 
0.3μm. The gold density is 19.3 g/ml with refractive index 0.47 and absorption 1. According 
to gold density, the appropriate aqueous sucrose density gradient is 8 and 24 % with 14 ml 
total volume (average sucrose density = 1.064 g/ml). After injecting gradient in the disc, 
0.5ml dodecane was injected to prevent evaporation of the fluid from the rotating disc. 
According to the particles size and density, the recommended speed was 15396 RPM with 10 
minutes running .Instrument calibrated by 0.483μm PVC with density 1.385g/ml. The volume 
of the measured samples was 100 µl [23]. 
SDS-PAGE 
12% acrylamide gel was used.  The samples were centrifuged for 10 minutes at 13000 rpm, 
then the supernatants were discarded and the pellet washed 2 times with 400µl PBS and 
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transferred to new Eppendorf tubes, then the pellet was incubated with 10 µl SDS for 5 
minutes at 85oC. 10µl was loaded in each well of the gel.  
 
2.3 Experiments 
Citrate-stabilized GNPs 
    The size of 24 nm citrate stabilized GNPs was measured in water and PBS by DLS. The 
particles size in PBS before and after adding 0.1 mg/ml PGB1 was measured by disc 
centrifuge and DLS. To study the effect of cow serum on the aggregation of GNPs conjugated 
to PGB1, different concentrations of cow serum (1, 5, 10, 30 and 50%) was added to GNPs 
incubated 30 minutes with 1mg/ml PGB1. Then, the samples was incubated another 30 
minutes. The control samples were GNPs dispersed in PBS, 1 mg/ml PGB1 with GNPs, 50% 
cow serum and 50% cow serum with 1 mg/ml PGB1. The size was measured by disc 
centrifuge. The proteins bound to conjugated GNPs were examined and separated by SDS-
PAGE. The negative and positive controls were 30% cow serum and 30% cow serum with 
GNPs respectively. Another experiment was done using water as a buffer and 0.1 mg/ml 
PGB1 with GNPs, which incubated 30 minutes then 5, 10, 60 and 80% cow serum, were 
added. The size was measured by DLS with GNPs and 0.1 mg/ml PGB1 conjugated GNPs as 
controls. SDS-PAGE was run for 1mg/ml PGB1 with 0.113 mg/ml GNPs and 10, 60 and 80% 
cow serum. The controls were 0.1 mg/ml PGB1 with 80% cow serum (negative control) and 
GNP with 80% cow serum (positive control). This experiment was repeated replacing cow 
serum by FCS.To investigate the interactions between GNPs and cow serum and FCS, 
different concentrations of cow serum (1, 5, 10, 50 and 80%) were prepared using PBS, then 
GNPs were added and incubated for 60 minutes. The total volume of the sample was 200 µl, 
divided equally for disc centrifuge and DLS measurements.  The same experiments had been 
done replacing cow serum by FCS.  The effect of IgG on the aggregation of GNPs was studied 
by preparing different concentrations of IgG (0.001, 0.0.1, 0.1, 0.5 and 1 mg/ml)  and 
measuring the size by DLS. Different PGB1 concentrations (0.1, 0.5, 1, 2 and 3 mg/ml) with 
GNPs in water and PBS were incubated 30 minutes.  The total volume of the sample was 200 
µl, divided equally between disc centrifuge and DLS to measure the particles size. The size of 
GNPs in water and PBS was measured after one year from DLS measurement. This time the 
size was also measured by disc centrifuge. 
     Another GNPs with concentration 2.5 mM and 26 nm were used to check the reason of 
the aggregation, is it due to IgG or the particles itself were aggregated. Most of the 
experiments were repeated using these particles including the particles size, PGB1 
conjugated particles and PGB1 conjugated particles in cow serum.  
 
Carboxylated GNPs 
     PGB1 was conjugated to 20 nm carboxylated particles according to cytodiagnostics 
protocol [24]. Then, different concentrations of cow serum (10, 20, 40, 60 and 80%) were 
incubated 30 minutes with the conjugated and unconjugated carboxylated GNPs. Size was 
measured by DLS and SDS-PAGE was run for these samples. 
12 
 
Biotiylated GNPs 
 Biotinylated GNPs, 20 nm were incubated 30 minutes with different streptavidin to biotin 
ratios (0.1, 0.5, 1, 1.5, 2 and 5), measuring the size by DLS. Different concentrations of cow 
serum (1, 5, 10, 50 and 80%) were incubated for 1 hour with biotinylated GNPs conjugated 
to streptavidin. The size of the particles was measured by DLS and disc centrifuge. To study 
the behavior of streptavidin, Alexa flour 488 dye was used to label streptavidin [25]. The 
fluorescence was measured by fluorometer. 
3. Results and discussion 
Citrate-stabilized GNPs 
3.1 Particles size (in water and PBS) 
 
     The stability of GNPs in water and PBS was measured by DLS. Fig.1 shows a big difference 
in the size of the particles dispersed in water and in PBS. The size of GNPs in water was 
around 28 nm with a small peak at 5560nm, which could be aggregated particles. GNPs in 
PBS were aggregated giving a monodisperse peak at 1106 nm. NaCl in PBS played an 
important role in the aggregation of the particles as Na+ bound to the carboxylic acid of the 
citric acid groups at GNPs surface, which neutralized the stabilizing electrostatic forces (EES) 
causing van der Waals forces (Evdw) to drive instantaneous and irreversible aggregation of the 
GNPs, giving a dark grey solution (fig.1) [26]. 
 
Fig.1: DLS measurements of GNPs in water (cyan) and PBS (red). 
 
 
3.2 How the aggregation of GNPs could be prevented? 
 
    The order of preparing the sample controlled the aggregation of the particles. In fig.2, 
there was a difference in the color of GNPs between A, B and C. In figure 2A, GNPs were 
stabilized in the water and did not aggregate (purple color). In figure 2B, GNPs were 
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aggregated immediately by adding PBS, so the color changed to dark grey. In figure 2C, PBS 
was added to the particles after adding 1mg/ml PGB1. The aggregation of GNPs in PBS when 
PGB1 added first and when added after PBS was completely different (fig.3). Scheme 1 
suggests what is happening when PGB1 is added first and when it is added after PBS. Once, 
PBS added to the particles, they started to aggregate (fig.1) but the surface of the particles 
complex, which exposed to the PBS, could bind to PGB1 protein and cover the outer surface 
of the complexes. When PGB1 was added first, the particles did not aggregate as PGB1 was 
forming a layer around the particles and preventing their aggregation so the color of the 
particles remained purple (fig.2C) [26]. 
 
Fig.2:A. GNPs in water ,B. GNPs in PBS and C. GNPs with 1mg/ml PGB1 and after that PBS were added. 
 
 
Fig.3: Disc centrifuge measurements of GNPs in PBS (green),GNPs in PBS after adding 0.1mg/ml PGB1(cyan) and 
GNPs dissolved in PBS and after that 0.1mg/ml PGB1 was added (red). 
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Scheme1: The aggregation of GNPs in PBS before and after adding 1mg/ml PGB1. 
 
3.3 Effect of cow serum on the aggregation of GNPs conjugated to PGB1 
 
     The aggregation of GNPs conjugated to 1mg/ml PGB1 and different cow serum 
concentrations (1, 5, 10, 30 and 50%) in PBS was measured using disc centrifuge (fig.4). In 
this experiment, there were four controls, one was only GNPs dissolved in PBS, the second 
was GNPs with 1mg/ml PGB1, the third was only 50% cow serum and the last one was 50% 
cow serum with 1mg/ml PGB1. By comparing the first two controls, a big difference was 
observed as GNPs with PGB1 had a single peak around 20 nm while GNPs sample had a wide 
peak covering a large range of sizes but with lower intensity, which an indication about the 
interactions between PGB1 and GNPs. In the last two controls, there was a difference 
between 50% cow serum sample and 50% cow serum with 1mg/ml PGB1. At 50%, cow 
serum with 1mg/ml PGB1, there was peak about 70 nm, which an indication about the 
interaction between PGB1 and IgG in cow serum. At 1% cow serum with PGB1 and GNPs, a 
very small peak appeared at 15 nm. By increasing cow serum concentration this peak 
became small and a bigger one appeared around 70 nm until 50 % cow serum at which the 
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small peak disappeared and only peak around 70 nm appeared, which was exactly the same 
as 50 % cow serum with PGB1 control sample. 
     At 1% cow serum almost all PGB1 covered GNPs and at the same time PGB1 interact with 
serum  and that is why the peak was shifted to a smaller size as the protein coated particles 
moved slower than the uncoated ones [18]. By increasing cow serum, concentration (5, 10 
and 30%) two peaks appeared, as part of PGB1 interacts with GNPs and another part with 
serum so both of the peaks could be seen. Going up to 50% cow serum the small peak 
disappeared and the curve fit exactly the 50 % cow serum with PGB1 control sample, which 
means that, may be all PGB1 left the particles and bound to Fc fragment of IgG in cow serum. 
A negative peak appears in most of the samples, which we cannot explain.  
 
 
 
Fig.4: Disc centrifuge measurements of 0.113 mg/mlGNPs with 1mg/ml PGB1and different cow serum 
concentrations (1, 5, 10, 30 and 50%). 
 
     To interpret more clearly the disc centrifuge data and to investigate what was bound to 
the particles, the particles were centrifuged down and SDS-Page gel was run on the pellet 
(fig.5).  The negative controls were 30% cow serum and 30%cow serum with 1mg/ml. The 
positive control was 30% cow serum with GNPs. 
     The first negative control (30% cow serum) had no bands, as nothing was precipitated 
during centrifugation of the sample. Second negative control (30% cow serum with 1mg/ml 
PGB1) had two bands, one was around 50 kDa and the other was around 15 kDa. It was 
thought that, these two bands were for the heavy and light chain of IgG as PGB1 bound to Fc 
fragment of IgG (this was agree with disc centrifuge curve, fig.4). At 1%, serum there was no 
bands appeared as the cow concentration was very low and GNPs with PGB1 could not be 
seen in SDS-PAGE gel (look at appendix I, fig.15). At 5%, there were two bands one for the 
heavy chain and one for the light chain of IgG, which an indication that there are interactions 
between GNPs and IgG. At 10%, another band started to appear (albumin) but very faint and 
the thickness of the two bands of IgG increases as IgG concentration increased. At 30% cow 
serum, albumin band appeared clearly, while IgG bands were the same. At the highest 
concentration (50%) IgG bands became faint and albumin was the same. 
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Fig.5: SDS-PAGE gel of GNPs with 1mg/ml PGB1and different cow serum concentrations.1.Ladder,2.30% 
serum3.30 % serum+GNPs,4.30%serum+1mg/ml PGB1,5. GNPs+1mg/ml PGB1+1%serum,6. GNPs+1mg/ml 
PGB1+5%serum7. GNPs+1mg/ml PGB1+10%serum 8.GNPs+1mg/ml PGB1+30%serum.9. GNPs+1mg/ml 
PGB1+50%serum. 
 
     From disc centrifuge measurements and SDS-PAGE, it was clear that PGB1 interacted with 
GNPs and at the same time with cow serum and that is why there were two peaks for all the 
samples of GNPs with PGB1 and cow serum. Nevertheless, it does not mean that there was 
no interaction between GNPs and cow serum. It was clear from the gel that by increasing 
cow serum concentration more IgG bound to the particles and PGB1 until at 50 % serum 
concentration which IgG bands decreased which might mean that PGB1 left GNPs and bound 
to IgG. As in the disc centrifuge the curve of the control sample (50% cow serum with 
1mg/ml) and 1mg/ml PGB1 with 10x GNP and 50% cow serum were the same. Albumin band 
became more intense as GNPs were stabilized and bound to albumin. 
 
     To study, what was happened in the system, the same experiment was done but using 
lower PGB1 concentration (0.1mg/ml) and replacing PBS by water (fig.6A). At 5% and 10% a 
large peak appeared at 2305 and 5560 nm respectively. By increasing cow serum 
concentration the aggregation decreased. Comparing 80% cow serum with GNPS and 80% 
cow serum with GNPs conjugated to PGB1, it was found that the first sample covering wide 
range of sizes. While for the sample with PGB1, it covered almost the same range but some 
aggregation sizes disappeared in-between as PGB1 covered part of GNPs surface so the 
surface area of GNPS exposed to cow serum decreased.  
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Fig.6: (A) DLS measurements of different cow serum concentrations (5, 10, 60 and 80%) with 0.1mg/ml PGB1 
and 10 xGNPs. (B) SDS-PAGE gel of different serum concentrations with 0.1mg/ml PGB1 and 0.113 mg/mlGNPs. 
1.Ladder,2.0.1mg/mlPGB1+80%cow serum,3.80%cow serum+GNPs,4.GNPs+0.1mg/mlPGB1+10%cow serum,5. 
GNPs+0.1mg/mlPGB1+60%cow serum,6. GNPs+0.1mg/mlPGB1+80%cow serum. 
 
         SDS-Page was run for 10, 60 and 80% cow serum with GNPs conjugated to 
0.1mg/mlPGB1 with negative control, 0.1mg/ml PGB1 with 80% cow serum and positive 
control, GNPs with 80% cow serum (fig.6B). At 10%, cow serum the band of heavy and light 
chain IgG was more intense than 80% and it might be because more IgG bound and 
aggregated the particles and this was agree with the DLS measurements (fig.6A).  
      The aggregation of   GNPs conjugated PGB1 with FCS was lower than with cow serum 
(fig.7).  
Most aggregation was at 80% FCS sample. By decreasing FCS concentration the aggregation 
decreased but not so much and the smallest aggregation was at 5% FCS (fig.7A), unlike cow 
serum at which the highest aggregation was at 5 and 10 % cow serum (fig.6A). 
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SDS-PAGE (fig.7B) of different FCS concentration with GNPs conjugated to PGB1 was totally 
different from SDS-PAGE of cow serum (fig.6B). Heavy and light chain IgG bands were 
unclear which an indication of the low amount of IgG bound to GNPs and this was agreed 
with the DLS measurements (fig.7A).  
 
 
 
 
 
 
Fig.7: (A) DLS measurements of different FCS concentrations (5, 10, 60 and 80%) with 0.1mg/ml PGB1 and 10 
xGNPs. (B) SDS-PAGE gel of different FCS concentrations with 0.1mg/ml PGB1 and 0.113 mg/ml GNPs. 
1.Ladder,2.0.1mg/mlPGB1+80%FCS,3.80%FCS+GNPs,4. GNPs+0.1mg/mlPGB1+10%FCS,5. 
GNPs+0.1mg/mlPGB1+60%FCS,6.GNPs+0.1mg/mlPGB1+80%FCS. 
 
3.4 The interactions between GNPs and cow serum  
 
      In this part, different cow serum concentrations were incubated for one hour with GNPs 
in PBS. There was a difference between measurements of disc centrifuge and DLS (fig.8). In 
0
5
10
15
20
25
1 10 100 1000 10000 100000 1000000 10000000100000000
0.113mg/mlGNPs
0.1mg/ml PGB1+GNPs
80%FCS+GNPs
GNPs+0.1mg/mlPGB1+5%FCS
GNPs+0.1mg/mlPGB1+10%FCS
GNPs+0.1mg/ml PGB1+60% FCS
GNPs+0.1mg/mlPGB1+80%FCS
Diameter (nm) 
In
te
n
si
ty
 
A. 
B. 
1                  2             3             4            5            6 
18
19 
 
disc centrifuge (fig.8A), it seems that there was no aggregation of the particles but there was 
still interaction between GNPs and cow serum as the intensity increases by increasing cow 
serum concentration. The aggregation is very clear in DLS measurements (fig.8B). By 
increasing cow concentration, the size of the particles increased and the peak became flat 
covering a wide range of different size (at 50% and 80% cow serum). At 50% cow serum 
couldn’t be measured alone in DLS. 
 
 
 
 
 
 
Fig.8: (A) Disc centrifuge and (B) DLS measurements of different cow serum (1, 5, 10, 50 and 80%) 
concentrations with0.113 mg/ml GNPs in PBS. 
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3.5 The interactions between FCS and GNPs 
 
     Different FCS concentrations were incubated for one hour with GNPs in PBS. At 1% FCS 
(fig.9A), the peak was broad as the concentration was very low so GNPs was still exposed to 
PBS which enhance the aggregation. By increasing FCS concentration the peak became 
sharper as the particles completely surrounded by FCS and bound to the particles. In the DLS 
the data were completely different as the aggregation decreased by increasing FCS 
concentration from 1% to 10% but after that at 50 and 80 % the size increased again but not 
like 1%, still 1% had the biggest size (fig.9B). 
 
 
 
Fig.9: (A) Disc centrifuge and (B) DLS measurements of different FCS (1, 5, 10, 50 and 80%) with 0.113 mg/ml 
GNPs in PBS. 
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     In general, the behaviour of GNPs in cow and calf serum in the DLS measurements 
(because in disc centrifuge, the size was almost the same) was different as cow serum 
caused bigger aggregation of the particles than FCS and it might be due to high IgG content 
in cow serum than calf serum. Therefore, in the next section the effect of different 
concentrations of IgG on GNPs was studied using water as a buffer to elucidate just the 
effect of IgG without any aggregation enhancing molecules. 
 
3.6 The Effect of IgG concentration on GNPs aggregations 
 
    To study the effect of IgG on GNPs aggregation, GNPs were incubated with different IgG 
concentrations. The highest aggregation of GNPs was at 0.001mg/ml IgG and by increasing 
IgG concentration the aggregation of the particles decreased (fig.10). 
     At low IgG concentrations (0.001 and 0.1 mg/ml), one IgG molecule might bound to more 
than one GNP at the same time forming a bridge between them causing high aggregation of 
the particles. By increasing IgG concentration, each IgG molecule bound to GNP, which 
decreased the probability of IgG to bind to other GNPs, so the aggregation decreased. At 
very high IgG concentration, there were a high amount of IgG which forming a monolayer 
around the particles quickly which prevents the aggregation of the particles [16]. 
  
Fig.10: DLS measurements of different IgG concentrations with 0.113 mg/ml GNPs in water. 
 
 
3.7 The interactions between PGB1 and GNPs  
 
     The interaction between GNPs dispersed in water and PGB1 was measured using DLS and 
disc centrifuge (fig.11). In the disc centrifuge, a small increase in the size by increasing PGB1 
concentration was observed which an indication that PGB1 bound to GNPs.  This small 
increase because PGB1 is a small protein. For DLS measurements, the size of the particles 
increased by increasing PGB1 concentration which also an indication about the interaction 
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between PGB1 and GNPs. There were differences between results of disc centrifuge and DLS. 
The size of GNPs could not be measured by DLS, as data were unacceptable while in disc 
centrifuge it was measured with size around 18 nm. The size of GNPs could be measured by 
DLS one year before but may be during this time the aggregation increased as in fig.1 there 
was an aggregation started to grow at 5560 nm.  
 
 
 
 
 
Fig.11: (A) Disc centrifuge and (B) DLS measurements of different PGB1 concentrations (0.1, 0.5, 1, 2, and 
3mg/ml) with 0.113 mg/ml GNPs in water. 
 
   Adding PBS instead of water after adding PGB1 to the particles gave also, a small shift in 
the peaks in disc centrifuge measurements (fig.12A) but the particles did not aggregate 
which means that PGB1 bound to the particles and protected them from PBS. 
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     DLS (fig.12B) giving a large variation in the size and the data of some PGB1 concentrations 
were unacceptable. It might due to the aggregation of GNPs as these experiments had be 
done after one year from previous measurements and the stability of the particles has to be 
checked. 
 
 
 
 
 
 
 
 
 
Fig.12: (A) Disc centrifuge and (B) DLS measurements of different PGB1 concentrations in PBS. 
 
0
20
40
60
80
100
120
10 20 30 40 50 60 70
0.113mg/mlGNPs
0.1mg/mlPGB1
0.5mg/mlPGB1
1mg/mlPGB1
2mg/mlPGB1
3mg/mlPGB1
Diameter (nm) 
In
te
n
si
ty
 
0
20
40
60
80
100
0 100 200 300 400
0.1PGB1
2PGB1
3PGB1
In
te
n
si
ty
 
Diameter (nm) 
A. 
B. 
A. 
B. 
24 
 
 
3.8 Stability of GNPs after one year 
 
      After one year, the stability of GNPs in water and PBS was measured again using DLS and 
disc centrifuge (fig.13). In the DLS, the data were unacceptable giving a large variation in the 
size so the machine could not calculate an average size. In  the disc centrifuge the data were 
acceptable (figure 1), particles in water has a single peak with maximum intensity around 
18.14nm but  in PBS, intensity decreases and the particles aggregated giving  a broad 
polydisperse peak. DLS has higher sensitivity to the aggregates and impurities than disc 
centrifuge so ,may be that is why the GNPs after one year couldn’t be measured by DLS 
although it was measured with the same method one year before [18] . 
 
 
 
 
Fig.13: Disc centrifuge measurement of GNPs in water (cyan) and PBS (red) after one year from DLS 
measurement (fig.1). 
 
   Other GNPs were used to check that the aggregation of particles was actually due to IgG 
content in cow serum and not due to the aggregation of the particles itself. The size of the 
particles in water and PBS was measured by disc centrifuge and DLS. Both of them gave 
acceptable results. The size of the particles in water was 23 nm measured by  disc centrifuge 
while in the DLS was 26 nm and this acceptable as DLS measured the hydrodynamic 
diameter so it was always more than the diameter measured by disc centrifuge. The size of 
the particles dissolved in PBS was 100 nm according to disc centrifuge data while in DLS 
there were two peaks one around 539 nm and 4774.3 nm. 
     Different concentrations of PGB1 with 2.5mM GNPs dissolved in PBS were incubated for 
30 minutes and the size was measured by disc centrifuge and DLS. In the disc centrifuge, a 
big difference in the size between GNPs dispersed in PBS and the particles with different 
1
11
21
31
41
51
61
71
81
91
101
10 100
PBS
water
Diameter (nm) 
In
te
n
si
ty
 
24
25 
 
PGB1 concentrations (0.1, 0.5, 1, 2 and 3 mg/ml). The size of the particles decreased by 
adding PGB1 and this was agreed with the data from the other gold particles. By increasing 
PGB1 concentration, just a small shift in the peaks towards bigger size could be seen but 
there was no aggregation. The same with DLS measurements, also small increase in the size 
but at 3 mg/ml PGB1 the size decreased which might means that all the particles totally 
covered by PGB1 and no particle exposed to PBS so, there was no any small aggregation.  
      The aggregation of GNPs conjugated to 1mg/ml PGB1 and different cow serum 
concentrations (1, 5, 10, 30 and 50%) in PBS was measured using disc centrifuge (fig.14) and 
DLS. The DLS data were unacceptable while the particles size could be measured by disc 
centrifuge. At 1% cow serum, a small single peak appeared at 16 nm which was nearly the 
same as the peak of the control sample (1mg/ml PGB1 with 2.5mM GNPs). The reason for 
that was the low concentration of cow serum. At 5% cow serum, another peak appeared at 
78 nm which an indication about the aggregation of the particles. The aggregation increased 
by increasing serum concentration and the biggest aggregation was at 50 % cow serum (blue 
curve, fig.15) 
 
      
 
 
Fig.14: Disc centrifuge measurements of 2.5mM GNPs with 1 mg/mlPGB1 and different cow serum 
concentrations (1, 5, 10, and 30%). 
     
 
Carboxylated GNPs 
     Conjugation of carboxylated GNPs with PGB1 had been tried and incubated with different 
concentrations of IgG, cow and calf serum. Then, the size of the conjugated paricles was 
measured by DLS and disc centrifuge.  It seems that this system is complicated and no 
significant difference between conjugated and unconjugated carboxylated GNPs could be 
detected. 
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 Biotinylated GNPs 
      There was no difference between conjugated and unconjugated streptavidin particles 
with different concentrations of cow serum could be seen. It might be that there was no 
interactions between streptavidin and cow serum. To study the behavior of streptavidin, it 
was diluted 10 times (0.05 mg/ml) and labeled with Alexa flour 488. The fluorescence was 
measured using fluorimeter but the signal was very noisy as the streptavidin concentration 
was very low. 
4. Conclusions 
 
 The water stabilizes the particles while PBS aggregates them.  
 
 
 These aggregations can be controlled by conjugating PGB1 protein to the particles 
before adding PBS as PGB1 binds to GNPs surfaces.  
 
 
 
 PGB1 conjugated to particles cannot be seen in SDS-PAGE.  
 
 PGB1 binds to IgG of cow serum.  
 
 
 Low cow serum concentration aggregates GNPs more than higher concentrations and 
more than calf serum.  
 
 
 Aggregations of GNPs depends on IgG concentration, i.e. low concentration causes 
high aggregation, medium concentration causes medium aggregations, high 
concentration  causes low aggregations. 
 
 
 The high aggregated samples cannot be measured by DLS.  
 
 
 
 The size of particles using DLS is bigger than disc centrifuge as it measures 
hydrodynamic diameter. 
 
 
 The stability of GNPs is changing over time (particles aggregated after one year). 
 
 
 
 Carboxylated and biotinylated GNPs are complex systems to work with. 
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5. Future work 
 
 Study the effect of GNPs size on the protein corona. 
 
 Run gel for PGB1 conjugated 2.5mM GNPs with different concentrations of cow and 
FCS. 
 
 
 More studies on carboxylated GNPs. 
 
 Increase the streptavidin concentration used for fluorescence labelling by Alexa flour 
488.  
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Appendix I 
 
Fig.15:SDS-PAGE of different PGB1 concentration with 0.113 mg/ml GNPs.(1) Ladder, (2) 3mg/ml PGB1, (3) 
GNPs+0.1mg/ml PGB1,(4) GNPs+0.5mg/ml PGB1, (5) GNPs+0.1mg/ml PGB1, (6) GNPs+1mg/ml PGB1, (7) 
GNPs+0.1mg/ml PGB1 and (8) GNPs+0.1mg/ml PGB1. 
 
Appendix II 
 
 
 
Fig.16: The general structure of IgG. 
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Fig.17: PGB1 structure from pdb viewer with ID 1pgb. 
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